Thermo Fisher rolls out 3,000 and 5,000 L single-use bioreactors
WEBMar 16, 2021 · ABEC, for example, launched a 4,300 L bioreactor (with 3,500 L of working volume) in 2015, a 4,900 L system with a 4,000 L working volume in 2017, and in 2019 launched a 7,500 L single-use bioreactor with a working volume up to 6,000 L. And now Thermo Fisher has joined the fold, launching the 3,000 L and 5,000 L HyPerforma …
Bioprocess Insider
WEBSep 23 - Sep 26, 2024. Sep 23 - Sep 26, 2024. Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More.
Manufacturing recent news | BioProcess International
WEBSep 23 - Sep 26, 2024. Sep 23 - Sep 26, 2024. Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More.
Thermo eyes $50bn M&A in coming years - BioProcess Insider
WEBMay 19, 2023 · Deal-Making. Bioprocess Insider. Thermo Fisher eyes up to $50bn M&A in coming yearsThermo Fisher eyes up to $50bn M&A in coming years. Not shy of multi-billion-dollar acquisitions, Thermo Fisher says it expects to spend another $40-50 billion on “disciplined” M&A. Dan Stanton, Editorial director. May 19, 2023.
Upstream Single-Use Bioprocessing Systems Upstream Single-Use ...
WEBSingle-use technologies (SUTs) now make up a large percentage of small- and mid-scale biopharmaceutical manufacturing, particularly in clinical testing and research and development (R&D). Upstream SUT includes disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and …
Evolve to build plasmid plant in Texas - BioProcess Insider
WEBDec 13, 2021 · The plant will be over 200,000 square feet and is set to have a production capacity of one million litres of plasma annually, with a planned expansion to up this to two million litres in the future. According to the firm, the plant will be the first to use Evolve’s propriety technology, PlasmaCap Expanded Bed Absorption (EBA).
Chromatography recent news | BioProcess International
WEBJul 29, 2024. Simplifying Downstream Processing: Innovative Solutions for Filtration and Chromatography. by Mark A. Perreault, Adam Nelson. Jun 12, 2024. Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media. by BPI Contributor.
Business recent news | BioProcess International
WEBOct 17, 2018 · by BPI Editors. Jul 31, 2024. End-to-End Services for Biologics Manufacturing: From Gene to Product. by Thilo Kamphausen, Kai Pohlmeyer. Jul 31, 2024. Vocational Schools Build Careers in Bioprocessing Biotechnology. by Jared Auclair. Jul 30, 2024. Pre-Clinical & Clinical Trials.
A Decade of Bioreactor and Upstream Technologies A Decade …
WEBA Decade of Bioreactor and Upstream TechnologiesA Decade of Bioreactor and Upstream Technologies. Maribel Rios. June 1, 2012. 10 MinRead. A high-quality product begins with efficient upstream process equipment. Ten years ago, manufacturers were still warming up to single-use bioreactors, which were mainly rocking-bag–based solutions.
Review, Approval, and Marketing of Biosimilars in the United States
WEBDec 1, 2010 · During the past 30 years, advances in medicine and pharmaceutical research generated a new class of drugs called biologics. These drugs are complex proteins, carbohydrates, or other large molecules derived from biological sources ().By contrast with more traditional pharmaceuticals (small-molecule drugs), biologics are not synthesized …